Yag – Light Age, Inc.

October 23rd 2013 – Light Age, Inc. signs a nationwide representation and distribution agreement with Moore Medical LLC, a subsidiary of McKesson Medical-Surgical, to sell the Q-Clear™ Compact Laser System.

Marketing Light Age, inc. — Wed, 23 Oct 2013 05:00:00 +0000

Light Age, Inc. signs a nationwide representation and distribution agreement with Moore Medical LLC, a subsidiary of McKesson Medical-Surgical, to sell the Q-Clear Compact Laser System.

View or download the Press Release in PDF

[vc_tweetme type=”horizontal”]

Oct 23rd, 2013 – Light Age Inc., a Somerset, NJ based developer and manufacturer of advanced laser systems announces the signing of a nationwide representation and distribution agreement with Moore Medical LLC to sell the QClear Compact Laser System.

This increases the distribution and offering of this product to US Physicians, Podiatrists, Dermatologists, and Plastic Surgeons. Together, they expect also to reach organizations supporting Corrections facilities, the Veterans Administration, Indian Health Services, and others.

Delivering both 1064 nm and 532 nm, the Q-Clear Laser System has been cleared by the US FDA for the treatment of patients with onchomycosis (toenail fungus). the Q–Clear has been cleared by the US FDA since 2004 for more than two dozen indications including the removal of tattoos, vascular, and pigmented lesions. The Q-Clear provides revolutionary, minimally invasive, and highly effective laser treatments. Weighing in at just 35 pounds, it is portable and an affordable solution for the practitioner.

The Q Clear Laser System is a breakthrough in the treatment of nail fungus. In many cases, relief is achieved in as little as one session. Estimates are that more than 10% of the US population suffers symptoms of this ailment. Moore Medical LLC, a subsidiary of McKesson Medical-Surgical, is an Internet-enabled, multi-channel, specialty direct marketer and distributor of medical-surgical supplies, equipment and pharmaceuticals to approximately 120,000 healthcare practices, facilities and organizations in non-hospital settings nationwide. See www.mooremedical.com

“This is a great opportunity for both Light Age, Inc. and Moore Medical, LLC to provide our innovative Q-Clear to more practices nationwide, through the already established Moore Medical distribution network. That gives a great opportunity to more doctors to experience the best laser for treating Onychonycosis and other indications. As the clinical study submitted to the US FDA states: Statistical analysis of results indicates significant apparent clearing in 95% of the subjects with an average clearance of affected areas of 56±7% at 98% level of confidence. The protocol employed was extremely well tolerated by patients, no pain was reported, although some patients reported feeling a low-level sensation on some involved toenails.”

Says George Georgitsis, Director of Marketing at Light Age, Inc.

About Light Age, Inc.

Light Age, Inc. is a privately held US corporation, with principal offices in New Jersey. Born from a tradition of Scientific advancements, while focusing on the creation of innovative products that serve human needs, Light Age serves the global healthcare and aesthetic markets with industry leading Alexandrite and Nd:YAG laser systems. For more information contact Light Age’s sales or marketing department at 732-563-0600 or email us at sales@192.163.194.50, marketing@192.163.194.50 We are on the web at http://www.lightage.com

May 3rd, 2012 – Light Age, Inc. receives FDA approval for the Epicare-YAG™ Advanced, Variable-Pulse, Nd:YAG laser system.

Marketing Light Age, inc. — Thu, 03 May 2012 05:00:00 +0000

Light Age, Inc., inventors of the alexandite laser and other advanced solid-state laser technologies, announce a new, effective, Variable Pulse, Nd:YAG (Neodymium-Doped Yttrium-Aluminum-Garnet) Advanced Laser System for Medical and Aesthetic Treatments.

May 3rd, 2012 – Somerset, NJ: Light Age Inc., developer and manufacturer of advanced laser systems and related products, has received US FDA marketing approval for its EpiCare-YAG laser systems – intended for use in General and Aesthetic Surgery, Plastic Surgery, Gynecology, Dermatology,and Podiatry with multiple broad FDA approvals including: treatment of Vascular and Pigmented Lesions, reduction of Hypertrophic and Keloid Scars, Removal of Tattoos, and for stable long-term or Permanent Hair Reduction. These state-of-the-art EpiCare-YAG laser systems join the successful family of EpiCare high average power, variable pulse laser systems: the EpiCare-LP and EpiCare-LPX systems, define the state of the art for medical and cosmetic laser systems oiperating at 755 nm wavelengths, and the EpiCare-DUO, providing the highest level of both 755 nm and 1064 nm performance available.

The EpiCare-YAG completes and complements the EpiCare family by providing world-leading performance at 1064 nm. Like its kin, the EpiCare-YAG provides a highly sophisticated, powerful laser system that has unsurpassed capability and is versatile and feature rich, yet easy to use. It operates in either of two modes: a standard (3 – 300 ms pulse duration) mode for treating larger areas (up to 40 mm) and a special, high fluence mode – providing fluences up to 2500 J/cm^2 with pulse durations as short as 0.5 ms, ideal for treating most common lesions.

The EpiCare-YAG provides all the capabilities that are popular with the EpiCare lasers, including: high average power, variable pulse duration, large spot sizes, extremely uniform spot profiles, user-friendly operation with predictive maintenance and sophisticated diagnostic features, and the world’s only 21st Century user interface including the internet-savvy SmartScreen guidance and management system. As with the LPX and DUO systems, the EpiCare-YAG is the fastest systems at its wavelength, and provides the lowest cost per treatment, helping to reduce the cost-of-care.

“The EpiCare-YAG follows the success of the LP, LPX at 755nm and the Duo at both 755nm and 1064nm, by providing another option to our customers who want the speed and sophistication of an EpiCare laser but feel they only need the 1064 nm wavelength,” says Dr. Donald Heller, CEO of Light Age Inc. “This follows Light Age’s policy of providing extra value and performance to our customers without trying to legislate how they might best use the extra capability provided. While providing the lowest treatment costs, these laser systems are intended to be the very best available, at any price.” “By developing the EpiCare-YAG, Light Age can provide the popular EpiCare line in all of the most popular wavelength formats. For more information regarding the EpiCare-YAG please contact Light Age, Inc.” – Ado Umezawa, Vice President of Sales.

For more information contact Light Age’s sales or marketing department at 732-563-0600 or email us at
sales@192.163.194.50, marketing@192.163.194.50

Click here to view or download the press release as a PDF file